Health science reports · 2026
Comparative Study on the Effect of Vitamin D Deficiency on Platelet Indices in COVID-19 and Hepatitis C Patients; an Observational Comparative Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Motaghi Mohammad, Ghaffari Kazem, Mansori Mahroo, Ghasemi Ali
Аннотация
BACKGROUND AND AIMS: Despite growing interest in the role of vitamin D in various infectious diseases, limited evidence exists regarding its association with platelet (PLT) parameters in patients with COVID-19 and Hepatitis C Virus (HCV) infection. This study aims to assess the relationship between serum vitamin D levels and PLT indices in patients with COVID-19 and chronic HCV.
METHODS: The study included 113 patients with confirmed COVID-19 and 97 patients with chronic HCV infection. All participants were classified into two subgroups based on their vitamin D status (deficient vs. non-deficient). The chi-square test (χ2) or Fisher exact test was used to compare the results between the two groups.
RESULTS: Patients with COVID-19 had significantly lower levels of vitamin D compared with HCV patients (p < 0.001). PLT counts were lower in the COVID-19 group, and MPV, PDW, and inflammatory markers (PLR, MPR, and MLR) were significantly higher. Also, a significant negative correlation was observed between vitamin D levels and MPV in both groups (p < 0.001). In patients with vitamin D deficiency, PLT and inflammatory changes were more pronounced in COVID-19 than in HCV.
CONCLUSION: The results of this study showed that COVID-19 patients had lower vitamin D levels, lower PLT counts, and higher indices of platelet activation compared with HCV patients. These changes are associated with the severity of the inflammatory response in COVID-19 and could be part of the mechanisms that cause thrombotic complications in this disease.
METHODS: The study included 113 patients with confirmed COVID-19 and 97 patients with chronic HCV infection. All participants were classified into two subgroups based on their vitamin D status (deficient vs. non-deficient). The chi-square test (χ2) or Fisher exact test was used to compare the results between the two groups.
RESULTS: Patients with COVID-19 had significantly lower levels of vitamin D compared with HCV patients (p < 0.001). PLT counts were lower in the COVID-19 group, and MPV, PDW, and inflammatory markers (PLR, MPR, and MLR) were significantly higher. Also, a significant negative correlation was observed between vitamin D levels and MPV in both groups (p < 0.001). In patients with vitamin D deficiency, PLT and inflammatory changes were more pronounced in COVID-19 than in HCV.
CONCLUSION: The results of this study showed that COVID-19 patients had lower vitamin D levels, lower PLT counts, and higher indices of platelet activation compared with HCV patients. These changes are associated with the severity of the inflammatory response in COVID-19 and could be part of the mechanisms that cause thrombotic complications in this disease.